We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Home
Services
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
A group of investors advised by Munich-based Rigeto Unternehmerkapital GmbH ("Rigeto") has acquired prevention-center as an add-on to the Matignon Group.
VISCHER advised Mosanna Therapeutics AG in closing an extension of the Seed Financing Round with Supermoon Capital and High-Tech Gründerfonds.
The shareholders of the Mimacom Flowable Group ("MFG") have sold MFG to the private equity investment house Ardian, accompanied by a reinvestment of the management. The transaction was completed on 19 April 2023. Headquartered in...
ATANIS Biotech AG, a Swiss biotechnology company specializing in functional allergy diagnosis, announced the successful completion of a significant capital increase.
Intel Capital, a leading investor in the future of compute, has invested in UNISERS AG, a Swiss semiconductor metrology company that identifies invisible contamination-caused defects in semiconductor materials. The USD14m seed financing round was led by Intel Capital, with participation from M Ventures, RSBG Ventures and Swisscom Ventures.
The Geneva-based cybersecurity firm e-Xpert Solutions SA and the Vaud-based One Step Beyond Group SA, which both specialized in consulting and cloud integration, have merged under a new structure called Swiss Expert Group.
BlackSheep MadTech Fund, managed by EUREKA! Venture SGR, the first European venture capital fund with an entrepreneurial background that invests in the marketing and advertising technology industry, has been the lead investor in the USD 5m series A investment round of Nexoya AG, a Swiss marketing analytics start up.
Medartis (SIX: MED), a Basel-based orthopedic company specializing in head and extremity surgery, recently signed an agreement with the private founders of KeriMedical, a Geneva-based private company specializing in the development and manufacture of implants for hand and wrist surgery, to acquire an additional 18% stake for a purchase price of approximately CHF 18m.
CODE41 SA, a community-centric Swiss watchmaking company, has increased its share capital by issuing participation certificates in the form of ledger-based securities, thanks to the tokenisation technology of Taurus SA and the opensource smart contract published by CMTA.
Oculis Holding AG ("Oculis") a global biopharmaceutical company purposefully driven to save sight and improve eye care, listed its shares on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp. (“EBAC”).
Displaying results 1 to 10 out of 145